SCAI: CARDia Data Find Diabetic Patients With Complex Heart Disease Can Safely Choose PCI


September 2, 2008 (Munich, Germany) - Investigators from the United Kingdom presented the results of CARDia (Coronary Artery Revascularization in Diabetes), a clinical trial comparing percutaneous coronary intervention (PCI) vs. coronary artery bypass grafting (CABG) in in diabetic patients with multivessel disease typically considered to be poor candidates for angioplasty and stenting.

Preliminary results of the CARDia trial at one year show no apparent difference between CABG and PCI in terms of the composite endpoints of death, non fatal MI and non fatal stroke (10.2% vs. 11.6%, p=0.63). In addition, the PCI patients experienced fewer strokes and less bleeding.

Since the combination of diabetes and multi-vessel coronary artery disease has long been considered the domain of surgeons, their findings will surprize the Cardiology community.